Evidence map›Paper›PMID 36410808›Full record

ArticleBMJ open2022

Diabetes incidence in subjects with PREDIABetes from ReUNion Island: the PREDIABRUN observational cohort study protocol.

Norah Anthony, Léa Bruneau, Sebastien Leruste, Jean-Marc Franco, Alain Domercq, Christine Kowalczyk, Estelle Nobecourt, C Marimoutou

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04463160 (Study of the Factors Favoring the Transition From Prediabetes to Diabetes on Reunion Island. Impact of the "Say No to Diabetes" Intervention.), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04463160 narecruitingnot on this map

Study of the Factors Favoring the Transition From Prediabetes to Diabetes on Reunion Island. Impact of the "Say No to Diabetes" Intervention.

TypeinterventionalSponsorCentre Hospitalier Universitaire de la RéunionRan2019 to 2026Enrolled2,000ConditionsDiabetesArmsprevention program for prediabetes "Say No to Diabetes"
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Norah AnthonyInstitut national de la santé et de la recherche, CIC 1410, Saint Pierre, La Réunion, France a-norah@hotmail.fr.ORCID 0000-0002-2738-0336
Léa BruneauInstitut national de la santé et de la recherche, CIC 1410, Saint Pierre, La Réunion, France.
Sebastien LerusteInstitut national de la santé et de la recherche, CIC 1410, Saint Pierre, La Réunion, France.
Jean-Marc FrancoInstitut national de la santé et de la recherche, CIC 1410, Saint Pierre, La Réunion, France.
Alain DomercqCollège des généralistes enseignants de l'océan indien, La Réunion, France.
Christine KowalczykUnion régionale des médecins libéraux Océan Indien (URML), La Réunion, France.
Estelle NobecourtInstitut national de la santé et de la recherche, CIC 1410, Saint Pierre, La Réunion, France.
C MarimoutouInstitut national de la santé et de la recherche, CIC 1410, Saint Pierre, La Réunion, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionImproved knowledge of prediabetic subjects' profile and their risk of developing type 2 diabetes mellitus (T2DM) would enhance secondary prevention. The primary objective is to describe factors associated with incident T2DM in subjects with pre-diabetes diagnosed in primary care. METHODS AND ANALYSIS: The study is based on Reunion Island, a French overseas region that experiences a particularly high disease burden of T2DM. This is an observational, non-randomised prospective cohort study conducted in primary care in which private general practitioner (GP) investigators recruit participants with pre-diabetes from their practices regardless of the initial motive for consultation. Pre-diabetes is defined by WHO criteria, that is, fasting plasma glucose between 1.10 g/L and 1.25 g/L and/or plasma glucose 2 hours after ingestion of 75 g of glucose (2-hour post load plasma glucose) between 1.40 g/L and 1.99 g/L. The design is based on an annual follow-up by the GP (according to French National Health Authority recommendations) with collection of clinical and laboratory data and specific lifestyle questionnaires answered by telephone at three time points: inclusion, and at 2-year and 5-year follow-up visits. Follow-up clinical and laboratory data are collected by the investigating GP as part of the study, and study-specific laboratory collections (serum, DNA and urine) will be obtained 2 and 5 years after inclusion. The primary outcome is transition to T2DM. ETHICS AND DISSEMINATION: This protocol has been approved by the research ethics committee of Saint Etienne (CPP Saint Etienne reference number: 2019-03). Enrolment began in August 2019. Results will be disseminated in at least three papers published in peer-reviewed medical journals, one oral communication and a large-scale communication to the local population and healthcare policymakers. TRIAL REGISTRATION NUMBER: NCT04463160 and ID-RCB 2018-A03106-49.

Indexed as

Diabetes Mellitus, Type 2Prediabetic StateBlood GlucoseCohort StudiesHumansIncidenceObservational Studies as TopicProspective StudiesReunionBlood GlucoseDIABETES & ENDOCRINOLOGYPREVENTIVE MEDICINEPRIMARY CAREPUBLIC HEALTH

Identifiers

PMID36410808
PMCPMC9680172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.